$CBDL .0008 starting
Top 10 Most Recent News Articles
2026 Community Impact Week: Slam Dunk for Community Unity
Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...
Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal
A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...
Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances
A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...
Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps
Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...
Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data
Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...
Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight
A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...
Continue Reading
NARUTO Card Game Set for June 2027 Global Launch
Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...
Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias
Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...
Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation
Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...
Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight
First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...
Continue ReadingTop 5 Most Recently Viewed Articles
KPN Successfully Completes Significant Share Buyback Initiative
KPN Completes a Major Share Buyback Royal KPN N.V. has successfully concluded its substantial property buyback program amounting to € 250 million. The initiative, which began in February, has seen the repurchase of over 62 million ordinary shares, emphasizing KPN's commitment to returning value to its shareholders. The Details of the Buyback Program Throughout this...
Continue Reading
Engaging Children's Book on Nutrition Aims for Healthy Futures
New Children's Book on Nutrition to Support Healthy Living Author and mother shares a delightful exploration of nutritious foods for kids. In an inspiring move to foster healthy habits among children, author Shelly Lu has unveiled her delightful new book, "Smart Foods for Kids: 25 Foods to fuel the brain and body." Aimed at families, this visually striking guide sheds...
Continue Reading
Innovative Trends in Bitcoin Gambling Platforms for 2025
Discovering the Future of Bitcoin Gambling in 2025 The digital gambling landscape, especially as it relates to Bitcoin and cryptocurrency platforms, is evolving rapidly. As the year progresses, numerous changes have been observed, particularly in August, showcasing advancements in speed, user experience, and overall engagement. Companies specializing in this sector, such...
Continue Reading
VivoPower Unveils Game-Changing Partnership with Flare Network
VivoPower and Flare Establish a Transformative Partnership VivoPower International PLC (NASDAQ: VVPR) has announced an exciting new partnership with Flare Network, which aims to deploy an impressive US$100 million in XRP to generate yields for institutional treasury management. This significant move showcases VivoPower's commitment to enhancing its digital treasury...
Continue Reading
Natural Grocers by Vitamin Cottage Announces Dividend Increase
Natural Grocers by Vitamin Cottage, Inc. Quarterly Dividend Announcement Increases Quarterly Cash Dividend by 25% to $0.15 per Common Share Today, Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) proudly announces that its Board of Directors has sanctioned a remarkable quarterly cash dividend of $0.15 per common share. This notable increase of 25% reflects the...
Continue Reading